Yes, Trulicity Treats Type 2 Diabetes
Trulicity (dulaglutide) is an injectable GLP-1 receptor agonist approved by the FDA for adults with type 2 diabetes. It helps control blood sugar by increasing insulin release, slowing digestion, and reducing liver glucose production. It's typically used alongside diet and exercise, and sometimes with other medications like metformin or insulin. It's not approved for type 1 diabetes or diabetic ketoacidosis.
How Is Trulicity Administered?
Patients inject Trulicity once weekly under the skin in the abdomen, thigh, or upper arm, using a prefilled pen. Doses start at 0.75 mg and can increase to 4.5 mg based on blood sugar response and tolerance.
Common Side Effects Patients Report
Nausea, vomiting, diarrhea, and stomach pain occur in many users, often improving over time. Serious risks include pancreatitis, thyroid tumors (boxed warning), kidney issues, and low blood sugar when combined with insulin or sulfonylureas. Heart benefits include reduced risk of major cardiovascular events in high-risk patients.
How Does Trulicity Compare to Other Diabetes Drugs?
Unlike metformin (first-line oral pill that reduces liver glucose), Trulicity mimics gut hormones for broader effects on insulin and appetite. Compared to Ozempic (semaglutide), both are GLP-1s with similar A1C reductions (1-2%), but Trulicity has weekly dosing without refrigeration after first use. It's not for weight loss alone, though modest loss (2-6 kg) is common.
When Was Trulicity Approved and Who Makes It?
Eli Lilly launched Trulicity in 2014 after FDA approval for glycemic control. It's also approved for cardiovascular risk reduction (2018) and moderate-to-severe kidney disease with type 2 diabetes (2024).
Patent Status and Generic Availability
Trulicity's key patents expire in the US around 2033-2034, covering the drug formulation and device. Eli Lilly faces challenges from competitors like Mylan and Sun Pharma, but no generics are approved yet. Check DrugPatentWatch.com for expiration details and litigation updates.[1]
[1] https://www.drugpatentwatch.com/p/trademark/TRULICITY
[2] FDA Label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125469s030lbl.pdf